or Try an Advanced Search...

    Technical Analysis for VIRI - Virios Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.40 -2.58% -0.01
    VIRI closed up 6.44 percent on Wednesday, May 15, 2024, on 52 percent of normal volume. It ran into resistance at its 50 day moving average.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical VIRI trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish -2.58%
    50 DMA Resistance Bearish -2.58%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.58%
    Lower Bollinger Band Walk Weakness -2.58%
    Wide Bands Range Expansion -2.58%
    Stochastic Buy Signal Bullish 3.69%
    Lower Bollinger Band Walk Weakness 3.69%
    Wide Bands Range Expansion 3.69%
    Lower Bollinger Band Touch Weakness 3.69%
    Oversold Stochastic Weakness 3.69%
    Older End-of-Day Signals for VIRI ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 1 hour ago
    10 DMA Support about 2 hours ago
    10 DMA Resistance about 2 hours ago
    Gap Down Partially Closed about 2 hours ago
    Gapped Down (Partial) about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VIRI Chart by TradingView
    Basic chart:

    Profile

    Virios Therapeutics, LLC, a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, LLC in July 2020. Virios Therapeutics, LLC was founded in 2012 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Rheumatology Fibromyalgia Antiviral Therapies

    Is VIRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Virios Therapeutics, Inc. (NASDAQ:VIRI) Q1 2024 Earnings Call Transcript
    May 13 VIRI: Results for Phase 2 Long COVID Trial Expected in 2H24…
    May 12 Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript
    May 9 Virios Therapeutics GAAP EPS of -$0.07 misses by $0.03
    May 9 Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
    May 2 Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
    Mar 26 Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
    Mar 1 Virios Therapeutics reports Q4 results
    Feb 29 Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
    Feb 28 Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
    See more VIRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.42
    52 Week Low 0.279
    Average Volume 317,462
    200-Day Moving Average 0.67
    50-Day Moving Average 0.42
    20-Day Moving Average 0.42
    10-Day Moving Average 0.40
    Average True Range 0.05
    RSI (14) 47.37
    ADX 14.52
    +DI 18.23
    -DI 19.48
    Chandelier Exit (Long, 3 ATRs) 0.34
    Chandelier Exit (Short, 3 ATRs) 0.48
    Upper Bollinger Bands 0.49
    Lower Bollinger Band 0.35
    Percent B (%b) 0.39
    BandWidth 31.34
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0057
    Fundamentals Value
    Market Cap 7.83 Million
    Num Shares 19.3 Million
    EPS -0.16
    Price-to-Earnings (P/E) Ratio -2.54
    Price-to-Sales 0.00
    Price-to-Book 1.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.49
    Resistance 3 (R3) 0.49 0.46 0.48
    Resistance 2 (R2) 0.46 0.44 0.46 0.47
    Resistance 1 (R1) 0.44 0.43 0.45 0.43 0.47
    Pivot Point 0.41 0.41 0.41 0.41 0.41
    Support 1 (S1) 0.38 0.39 0.39 0.38 0.35
    Support 2 (S2) 0.35 0.37 0.35 0.34
    Support 3 (S3) 0.32 0.35 0.34
    Support 4 (S4) 0.32